Update... As much as I like this stock long term, I don't trust it near term after taking all things "Friday" into consideration. Wait for lower. It could retest $54.
Perfect report. This is a good company folks. Up 6.25% in the ah's.... but no volume on that. I was a little disappointed with the forward guidance, albeit it came in at the top of the range. I can tell she (the ceo) plays things very conservatively. Hey I'm not a big fan of stocks under $5, but I told several friends today to buy stock in this company. I'll tell you what... it is going up. Just give it some time. IRA it.
Manners are a good thing. She's sharp. This company is a steal down here. Gotta love a BSME from ND. I wonder if Purdue rejected her. « Back Carrie Eglinton Manner President & Chief Executive Officer Carrie Eglinton Manner was named President and Chief Executive Officer of OraSure Technologies in June 2022 and brings more than 25 years of healthcare leadership and transformation expertise to the Company. Prior to joining OraSure, Ms. Manner was Senior Vice President, Advanced & General Diagnostics Clinical Solutions, at Quest Diagnostics. In that role, she was responsible for bringing innovative diagnostic solutions to market in the areas of women’s health, neurology, oncology, cardiovascular, metabolic, endocrinology, infectious disease, and immunology testing services, as well as drug monitoring and toxicology. She also led Quest’s pharmaceutical services, AmeriPath/Dermpath, and international businesses, as well as their molecular genetics team in pioneering next-generation sequencing innovation. Prior to Quest Diagnostics, Ms. Eglinton Manner served for 20 years in a variety of leadership roles at GE Healthcare, a division of General Electric (GE). A champion for inclusion and diversity, Ms. Eglinton Manner was co-chair for Quest’s African American Employee Business Network and GE’s Women’s Network. Ms. Manner received a B.S. degree in mechanical engineering from University of Notre Dame. ___________________________________________________ You go Carrie! Show the WS Ivy League MBA's which degree produces results. I doubt Boeing (despite that idiot Stoney saying 'I wanted a CEO with a little more experience'... whatever that f'ing means... I mean... he has no clue... as in clueless.)... f'd up. And the Boeing CEO only went to Iowa for his BSME. Purdue and the Irish... they wouldn't even let him in. #1 VZ STOCK PICK---->OSUR
Company Overview Headquartered in Bethlehem, PA, OraSure is a leader in the development, production, and distribution of point-of-care diagnostic and collection devices, and other technologies designed to detect or diagnose critical medical conditions. Our innovative products include rapid tests for COVID-19, HIV, HCV, syphilis, Ebola, and substance use. Bethlehem is home to our largest employee base and our state-of-the-art manufacturing facility. OraSure is also the parent company of DNA Genotek, Inc., in Ottawa, Canada, (In this particular case, we wont hold that against them. It is the Capitol) where our team develops world-class sample collection solutions. Our portfolio of sample collection solutions includes innovation to stabilize multiple types of DNA and RNA samples for years at ambient temperature. The self-collection products for saliva, gut, oral, fecal, vaginal, and skin samples are designed to maximize reach and access to testing, enabling breakthroughs in genomics research, diagnostics laboratories, the pharmaceutical industry, animal genomics, and personal genomics. We also have a collection device for first-void urine samples that is used to detect certain urological cancers and sexually transmitted infections, currently available in some global geographies and for research use.
Well lets all hope higher IQ's that don't judge folks by color or gender... prevail. She could have zebra stripes for all I f'ing care. This country has lost its f'ing mind.